Inventor · disambiguated record
Feng Qian
Also filed as: QIAN FENG · QIAN FENG FRANK
11 granted patents·11 pending applications·396 citations·filing 1994–2021
92Inventor score
Files withBRISTOL MYERS SQUIBB CO9ADVANCED MICRO DEVICES INC2GENZYME CORP2HYUNDAI ELECTRONICS AMERICA2NOVAGENESIS THERAPEUTIX HK LTD2
Top patents by PatentIndex Score
22 records- 0193US6169693B1Self-convergence of post-erase threshold voltages in a flash memory cell using transient responseHYUNDAI ELECTRONICS AMERICA·Filed 1999·Granted Jan 2, 2001·122 cites·7 claims
- 0293US6026026ASelf-convergence of post-erase threshold voltages in a flash memory cell using transient responseHYUNDAI ELECTRONICS AMERICA·Filed 1997·Granted Feb 15, 2000·125 cites·14 claims
- 0386US7534763B2Sustained release GLP-1 receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted May 19, 2009·5 cites·25 claims
- 0482US5712173AMethod of making semiconductor device with self-aligned insulatorADVANCED MICRO DEVICES INC·Filed 1996·Granted Jan 27, 1998·69 cites·8 claims
- 0576US7601715B2Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced thereinBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Oct 13, 2009·4 cites·12 claims
- 0675US7786098B2Fluoroalkoxycombretastatin derivatives, method for producing the same and use thereofZHEJIANG DADE PHARMACEUTICAL G·Filed 2006·Granted Aug 31, 2010·5 cites·10 claims
- 0769US5955767ASemiconductor device with self-aligned insulatorADVANCED MICRO DEVICES INC·Filed 1997·Granted Sep 21, 1999·34 cites·7 claims
- 0869US2015080399A1ATAZANAVIR SULFATE FORMULATIONS WITH IMPROVED pH EFFECTBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 0968US2019125875A1ATAZANAVIR SULFATE FORMULATIONS WITH IMPROVED Ph EFFECTBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 1065US6071717APolycystic kidney disease gene and proteinGENZYME CORP·Filed 1996·Granted Jun 6, 2000·15 cites·23 claims
- 1164US2018021436A1ATAZANAVIR SULFATE FORMULATIONS WITH IMPROVED Ph EFFECTBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 1258US7968718B2Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced thereinBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Jun 28, 2011·0 cites·1 claims
- 1358US5654170APolycystic kidney disease geneUNIV JOHNS HOPKINS·Filed 1994·Granted Aug 5, 1997·14 cites·9 claims
- 1458US2013203759A1ATAZANAVIR SULFATE FORMULATIONS WITH IMPROVED pH EFFECTNIKFAR FARANAK·Filed 2011·Application pending·0 cites
- 1554US2021196730A1Compound and use thereofNOVAGENESIS THERAPEUTIX SUZHOU LTD·Filed 2021·Application pending·0 cites
- 1651US2010022457A1Sustained release glp-1 receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Application pending·0 cites
- 1750US2010292246A1Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1h-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dioneBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
- 1850US2022280469A1Pharmaceutical compound and preparation method therefor and use thereofNOVAGENESIS THERAPEUTIX HK LTD·Filed 2020·Application pending·0 cites
- 1948US2006100209A1Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dioneGU CHONG-HUI·Filed 2005·Application pending·0 cites
- 2047US2022118057A1Albumin nanoparticles, the making method, and uses thereofNOVAGENESIS THERAPEUTIX HK LTD·Filed 2020·Application pending·0 cites
- 2137US2010261768A1Bioavailable Compositions of Amorphous Alpha-(N-Sulfonamido)Acetamide CompoundBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
- 2233US6867288B1Polycystic kidney disease geneGENZYME CORP·Filed 1995·Granted Mar 15, 2005·3 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Feng Qian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →